Besides the presence of medicines not included in the World Health Organization malaria treatment guidelines, the ease with which medications were procured without accurate diagnosis poses another major risk to patients' safety. In addition, this could have serious implications for the development of drug-resistant strains of Plasmodium parasites, particularly Falciparum, as novel treatments are not foreseeable in the near future. 
Zaidi ya madawa ambayo hayajapigwa marufuku na Shirika la AFya Duniani ya kukinga malaria, urahisi wa kutengeneza dawa hizi pia ni hatari kubwa kwa maisha ya wagonjwa.